|
ANXA7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.315600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.204400E-03 |
| Normal-vs-Stage2 |
1.697560E-02 |
| Normal-vs-Stage3 |
5.058000E-03 |
| Normal-vs-Stage4 |
1.945570E-02 |
| Stage1-vs-Stage2 |
3.528200E-01 |
| Stage1-vs-Stage3 |
4.311200E-01 |
| Stage1-vs-Stage4 |
6.074400E-01 |
| Stage2-vs-Stage3 |
7.605800E-01 |
| Stage2-vs-Stage4 |
7.369200E-01 |
| Stage3-vs-Stage4 |
9.351600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.083070E-03 |
| Normal-vs-AfricanAmerican |
7.792000E-01 |
| Normal-vs-Asian |
5.638200E-02 |
| Caucasian-vs-AfricanAmerican |
9.565700E-02 |
| Caucasian-vs-Asian |
6.591000E-01 |
| AfricanAmerican-vs-Asian |
2.564600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.141820E-03 |
| Normal-vs-Female |
7.199000E-03 |
| Male-vs-Female |
2.136200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.598000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.755200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.223100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.004300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.024000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.282400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.165400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.628400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.904600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.484800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.353400E-01 |
| Classical-VS-Follicular |
2.890200E-01 |
| Classical-VS-Other |
4.417400E-01 |
| Classical-VS-Normal |
2.754200E-02 |
| Tall-VS-Follicular |
2.121000E-01 |
| Tall-VS-Other |
3.075200E-01 |
| Tall-VS-Normal |
3.025400E-01 |
| Follicular-VS-Other |
8.292200E-01 |
| Follicular-VS-Normal |
1.010110E-02 |
| Other-VS-Normal |
7.419700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.969800E-04 |
| Normal-vs-N1 |
1.495830E-03 |
| N0-vs-N1 |
3.970400E-01 |
|
|
